4CPS-228 Effectiveness and security of new direct-acting antiviral agents for hcv

BACKGROUND: New direct-acting antivirals (DAAs) for chronic hepatitis C have been marketed and have changed the therapeutic landscape of this pathology. PURPOSE: To assess the effectiveness and security of new direct-acting antiviral agents for HCV. MATERIAL AND METHODS: Retrospective study carried...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur J Hosp Pharm
Autores principales: Marín, L Martínez Dueñas López, González, E González, Bonilla, AManzano, Romero, ACaballero, Sacristán, EGalindo, Chica, FMalpica, Romera, MCamacho
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Group 2018
Materias:
Section 4: Clinical pharmacy services
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535611/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.318
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares